[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
May 22, 1967


JAMA. 1967;200(8):717. doi:10.1001/jama.1967.03120210103021

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


One of the important stated objectives of the AMA Council on Drugs is to maintain an independent review of drugs and drug therapy in order to provide the medical profession with current, authoritative information in a manner and form that will satisfy the daily needs of physicians. A significant product of the Council's efforts towards achieving this objective is its annual publication, New Drugs. The wide acceptance of previous editions is an indication of the usefulness of this book to the practicing physician.

The 1967 edition, which is now available, retains the provenly useful format of the earlier editions. Its 51 chapters contain monographs presenting the Council's evaluation of most of the single-entity drugs that were introduced during the period 1957-1966. Each chapter is prefaced by an introductory statement in which the principal actions, uses, and adverse reactions of a particular class of drugs are briefly described, and older drugs,